News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - IPO
Merus Announces Pricing Of Initial Public Offering 5/19/2016
Oncobiologics Announces Pricing Of Its Initial Public Offering Of Units 5/13/2016
PAVmed (PAVMU) IPO Brings in $5.3 Million 4/29/2016
Proteostasis (PTI) Debuts Well-Below Expected Range But Still Raises $50 Millon in IPO 2/11/2016
BeiGene Announces Pricing Of Its Initial Public Offering 2/3/2016
Bay Area's First New Public Company of 2016 is OncoCyte 1/4/2016
GenScript Stages $68 Million IPO In Hong Kong 12/31/2015
The Children's Hospital of Philadelphia Participates In Spark Therapeutics (ONCE) Public Offering 12/16/2015
Accelerate Diagnostics (AXDX) Announces Pricing Of Public Offering Of Common Stock 12/10/2015
Voyager Therapeutics (VYGR) Announces Closing Of Initial Public Offering, Including Full Exercise Of Option To Purchase Additional Shares 11/17/2015
Wave Life Sciences (WVE) Raises $102 Million in IPO 11/11/2015
Voyager Therapeutics (VYGR) Reels in $70 Million in IPO 11/11/2015
MyoKardia Announces Closing Of Initial Public Offering 11/4/2015
Dimension Therapeutics Prices IPO at Lower End of the Range But Still Manages to Reel in $72 Million 10/22/2015
Strongbridge Biopharma Announces Pricing Of Its Initial U.S. Public Offering 10/16/2015
Cerecor Inc. Announces Pricing Of Initial Public Offering 10/15/2015
Aclaris (ACRS) Announces Pricing Of IPO 10/7/2015
NovoCure Prices $165 Million IPO 10/2/2015
Aclaris Therapeutics Sets Terms for $75 Million IPO 9/28/2015
Bioceres Files for an $81 Million U.S. IPO 9/28/2015
Mirna Sets Terms For $65 Million IPO 9/18/2015
Should You Invest in Nabriva IPO? 9/18/2015
Penumbra's $120M IPO Soars Early 9/18/2015
REGENXBIO Takes Center Stage With $139M IPO 9/17/2015
SynCardia Sets Terms For $28 Million IPO 9/16/2015
Gene Therapy Biotech REGENXBIO Increases Proposed IPO Price To $22 9/16/2015
Swedish Cancer Biotech Oasmia Narrows Range For IPO 9/16/2015
Cambridge’s Dimension Therapeutics Preps for $115 Million IPO 9/15/2015
Mirati Therapeutics  (MRTX) Announces Proposed Public Offering Of $80 Million Of Common Stock 9/15/2015
Intrexon Announces Closing Of $230 Million Public Offering Of Common Stock Including Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/26/2015
Benitec (BLT.AX) Announces Closing Of An Initial Public Offering In The United States With Listing On NASDAQ 8/24/2015
Inotek Pharmaceuticals Corporation (ITEK) Announces Pricing Of $68.9 Million Public Offering 8/13/2015
Zynerba Announces Pricing Of Its Initial Public Offering 8/5/2015
Adherium $35 Million ASX IPO To Expand Sales Of Digital Health Technology To Improve Medication Adherence 8/5/2015
Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 8/4/2015
Step Aside Juno (JUNO): World's Richest Doctor Pulls Off Largest Biotech IPO Ever 8/4/2015
vTv Therapeutics Announces Pricing Of Initial Public Offering 7/30/2015
Neos Therapeutics Announces Pricing Of Initial Public Offering 7/23/2015
Eye Sees More Gene Therapy: GenSight Biologics Files For A $100 Million IPO 7/7/2015
Bay Area's Natera Guns for a $175 Million IPO 7/2/2015
ConforMIS Prices $135 Million IPO 7/1/2015
Seres Therapeutics Raises $133M for State's Second-Largest Bio IPO, As Rival OpenBiome Grows 6/26/2015
Catabasis Pharmaceuticals, Inc. Shares Surge In Nasdaq Debut; Upsizes to Grab $60M in IPO 6/25/2015
Lantheus Holdings Prices IPO At $6, Below The Range 6/25/2015
GC Aesthetics Files For A $75 Million IPO 6/25/2015
Ritter Takes a Run at Public Markers With $20M IPO 6/24/2015
Benitec (BLT.AX) Files $70 Million IPO As Gene Therapy Booms 6/24/2015
Massachusetts Debuts Three Biotech IPOs for $235M As Market Roars 6/24/2015
Nivalis Therapeutics IPO Nets $88M 6/23/2015
Billionaire's Conkwest Aims for $172.5 Million IPO, While Neos Therapeutics Asks for $69 Million 6/22/2015
Biotech Neos Therapeutics Files for a $69 Million IPO 6/22/2015
Ousted Sanofi (SAN.PA) CEO's PureTech Nabs $171 Million in London IPO 6/22/2015
Celyad Scores $100.1 Million Gross Proceeds With NASDAQ IPO 6/19/2015
BioCardia Seeks $58 Million IPO 6/17/2015
vTv Therapeutics Files Registration Statement For Proposed Initial Public Offering 6/16/2015
Axovant (AXON) Takes Center Stage With Biggest Biotech IPO Ever, Baby-Faced CEO 6/15/2015
Axovant Prices IPO At $15, The Upper End Of The Range 6/11/2015
3SBio Inc. (SSRX) Sets Target Of $712 Million For Hong Kong IPO 5/28/2015
AbbVie (ABBV), Johnson & Johnson (JNJ) Floated as Possible Suitors For Freshly Flush Galapagos (GLPG.BR) 5/15/2015
Cystic Fibrosis Biotech Nivalis Therapeutics Files for $60 Million IPO 5/14/2015
aTyr Pharma Announces Closing Of Initial Public Offering 5/13/2015
Jaguar Animal Health Announces Pricing of IPO 5/13/2015
BiondVax Pharmaceuticals Announces Pricing Of U.S. IPO Of 1,910,000 Adss And Warrants To Purchase 1,910,000 Adss 5/12/2015
Adaptimmune Announces Closing Of IPO 5/11/2015
aTyr Pharma Announces Pricing Of Initial Public Offering 5/7/2015
Collegium Announces Pricing Of Its IPO 5/7/2015
GW Pharmaceuticals plc Announces The Closing Of U.S. Public Offering Of American Depositary Shares (Adss) Raising Approximately $179.2 Million On The NASDAQ Global Market 5/6/2015
Adaptimmune Announces Pricing Of IPO 5/6/2015
Blueprint Medicines (BPMC) Announces Closing of Initial Public Offering 5/5/2015
As Market Froths, Blueprint Medicines (BPMC) Debuts $147 Million IPO for Massachusetts' Biggest Recent IPO 5/1/2015
Shanghai Haohai Biological To Stage $305 Million IPO In Hong Kong 4/22/2015
Aduro Biotech (ADRO) Launches $119 Million IPO with Hot Cancer Tech 4/16/2015
KemPharm Sets Terms for $52 Million IPO 4/9/2015
IPOs Dropped 54 Percent in the First Quarter, As VC Investment Stays on the Sidelines 4/6/2015
aTyr Pharma $76 Million Series E Gets IPO Rumors Flying 4/2/2015
Botox Biotech Anterios Files For A $58 Million IPO 4/1/2015
After Exiting RTP, CoLucid Pharma Files with SEC for $86M IPO 4/1/2015
Cancer Gene Therapy Biotech MultiVir Files for a $70M IPO 3/30/2015
Bone Repair Biotech PolyPid Ltd. Yanks $20M IPO As Selloff Continues 3/27/2015
Applied DNA Sciences, Inc. (APDN) Prices $11.46 Million Public Offering 3/27/2015
SteadyMed (STDY) Announces Closing of Initial Public Offering 3/26/2015
Zhejiang ChiMin Pharma Stages $47 Million IPO In Shanghai 3/23/2015
Cancer Biotech Cellectis (ALCLS) Sets Terms For $129 Million IPO 3/20/2015
SteadyMed Launches IPO 3/10/2015
CALBIO15: Investors Will "Set Higher Bar" for Biotech IPOs in 2015 As Market Corrects, Says Panel 3/3/2015
VolitionRX Announces Exercise Of Over-Allotment Option In Previously Announced Public Offering 2/17/2015
Nexvet Biopharma plc Announces Pricing Of IPO 2/5/2015
BBI Life Sciences Stages $37 Million IPO in Hong Kong 2/5/2015
Flex Pharma (FLKS) Announces Closing Of Initial Public Offering 2/4/2015
TRACON Pharmaceuticals, Inc. Announces Pricing Of Initial Public Offering 1/30/2015
Unilife Corporation (UNIS) Announces Public Offering Of Common Stock 1/30/2015
Spark Therapeutics (ONCE) Announces Pricing of Its Initial Public Offering 1/30/2015
Cancer Biotech Kolltan Pharmaceuticals Inc. Withdraws $86 Million IPO 1/29/2015
Massachusetts's Inotek Pharmaceuticals Corporation Sets Terms for $65 Million IPO 1/23/2015
Silicon Valley Biotech Carbylan Therapeutics Files for $86 Million 1/2/2015
San Diego Biotech TRACON Pharmaceuticals, Inc. (TCON) Files for $58 Million IPO 12/30/2014
Growth Hormone Biotech Ascendis Pharma A/S Files For A $86 Million IPO 12/19/2014
The Biotech Year in Review, According To Bernstein 12/16/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data 12/3/2014
Universal Flu Vaccine Co BiondVax Pharmaceuticals Mulls NY IPO 11/24/2014
Neothetics Prices IPO 11/20/2014
Cancer Biotech Bellicum Pharmaceuticals, Inc. Files For $115 Million IPO 11/19/2014
Juno Therapeutics (JUNO) Files For IPO 11/17/2014
NeuroDerm Ltd. (NDRM) IPO Disappoints 11/14/2014
INC Research, Inc. (INCR) Announces Closing Of IPO 11/14/2014
CRO PRA Health Sciences Sets Terms For $400 Million IPO 11/5/2014
TPG-Backed Biotech Virobay Inc. Withdraws $50 Million IPO 11/3/2014
Meta-IQ Engages Back Bay Life Science Advisors In Preparation For Investment 10/20/2014
Xenon Pharmaceuticals Inc. Postpones IPO 10/20/2014
Neothetics Files To Raise $63 Million To Fight Fat With An Asthma Drug 10/20/2014
Insulin Biotech Dance Biopharma Withdraws $75 Million IPO 10/17/2014
Bone Biotech PolyPid Ltd. Files For A $24 Million IPO 10/16/2014
Atara Biotherapeutics (ATRA) Prices IPO Below The Range At $11 A Share 10/16/2014
Peanut Allergy Biotech DBV Technologies Sets Terms For $98 Million U.S. IPO 10/16/2014
EyeGate Pharma Postpones $25 Million IPO 10/3/2014
Lab Supplies Provider VWR Prices IPO Below Price Range 10/2/2014
SSF's Calithera Biosciences, Inc. (CALA) Prices IPO At $10 A Share, Below The Range 10/2/2014
German Alzheimer's Drug Developer Probiodrug AG Plans Amsterdam IPO 9/29/2014
Vitae Pharmaceuticals, Inc. (VTAE) Prices IPO At $8.00 A Share 9/24/2014
ProQR Therapeutics B.V. (PRQR) Prices IPO At $13 A Share 9/18/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Prices IPO At $6 A Share 9/18/2014
Tokai Pharmaceuticals Bags $97 Million For Prostate Cancer Drug In Upsized IPO 9/17/2014
Affimed Therapeutics AG (AFMD) Prices IPO At $7, Below The Range 9/12/2014
Diabetes/Alzheimer's Biotech Vitae Pharmaceuticals, Inc. Sets Terms For $60 Million IPO 9/9/2014
Boston's Rhythm Files For $86 Million IPO 8/28/2014
Adhesive Patch Biotech Zosano Pharma, Inc. Postpones $70 Million IPO 8/27/2014
South San Francisco's Calithera Biosciences, Inc. Seeks $80 Million In IPO 8/26/2014
Auris Medical AG (EARS) Prices IPO At $6 A Share, Raises $56 Million 8/6/2014
Loxo Oncology (LOXO) Prices Upsized IPO At Midpoint Of The Range, $13 A Share 8/1/2014
Catalent Pharma Solutions (CTLT) Prices IPO At Midpoint Range, Raises $871 Million 7/31/2014
Menlo Park's Avalanche Biotechnologies (AAVL) Rolls Onto Nasdaq, Raises $102 Million For Its IPO 7/31/2014
Israeli Biotech Macrocure Sets Terms for $75 Million IPO 7/31/2014
Epilepsy Biotech Marinus Pharmaceuticals (MRNS) Prices IPO At $10/Share 7/31/2014
VBL Therapeutics Announces Pricing Of Initial Public Offering 7/31/2014
BioBlast Pharma (ORPN) Prices Initial Public Offering Of $35,200,000 Of Ordinary Shares 7/31/2014
Sequenom Inc. (SQNM) Announces Closing Of Initial Public Offering 7/30/2014
TherapeuticsMD, Inc.  (TXMD) Announces $40 Million Offering Of Common Stock 7/30/2014
Immune Design Corporation (IMDZ) Announces Closing Of Initial Public Offering 7/30/2014
Intersect ENT Announces Closing Of Its Initial Public Offering 7/30/2014
New York Biotech ContraFect Corporation (CFRXU) Prices Upsized IPO At $5-6 A Share 7/29/2014
Massachusett's Ocular Therapeutix, Inc. (OCUL) Goes IPO At $13 A Share 7/25/2014
Bay Area's Intersect ENT Secures $55 Million After Hitting The Low End Of Its IPO Range 7/25/2014
SoCal's Atara Biotherapeutics IPO Delayed By New Test Results 7/24/2014
San Diego Biotech Pfenex Inc. (PFNX) Prices IPO At $6 Per Share, Below Downwardly Revised $8 Expectation 7/24/2014
Seattle Biotech Immune Design Corporation (IMDZ) Prices IPO At $12 Per Share, The Low End Of The Range 7/24/2014
Avalanche Biotechnologies Boosts IPO As 2 More Biotechs Go Public This Week 7/22/2014
Cancer Biotech Loxo Oncology Sets Terms For $57 Million IPO 7/22/2014
Auris Medical AG Commences Proposed Initial Public Offering Of Common Shares 7/21/2014
Catalent Pharma Solutions Sees IPO Of 42.5 Million Shares Priced Between $19-$22/Share 7/21/2014
Cambridge's SAGE Therapeutics Ups Proposed IPO Deal Size 7/17/2014
Seres Health Makes Push For First Drug, And IPO, Of Microbiome Era 7/17/2014
Absorbable Drugs Biotech Innocoll, Inc. Sets Terms For $75 Million IPO 7/16/2014
Genocea Biosciences Elects Not To Pursue Public Offering 7/16/2014
Menlo Park's Intersect ENT Latest Health/Bio IPO To Lower Target 7/16/2014
Rare Disease Biotech Bio Blast Pharma Sets Terms For $40 Million IPO 7/16/2014
Amgen (AMGN) Spinoff Atara Biotherapeutics Hikes IPO Target From $50 Million To $92 Million 7/15/2014
Ear Disease Biotech Otonomy, Inc. Files For An $86 Million IPO 7/14/2014
Southern California's Auspex Pharmaceuticals Prices Public Offering, Aims To Raise $60.6 Million 7/11/2014
ErgoMed To List On AIM Next Week After Raising GBP11 Million 7/9/2014
Italian Drugmaker Rottapharm Sets Price Range For IPO 7/8/2014
Durham Drug Developer Viamet Pharmaceuticals Files For $75 Million IPO 7/8/2014
Colorado's GlobeImmune, Inc. (GBIM) Prices IPO At $10 A Share, Below Expectations 7/2/2014
Cambridge's Minerva Neurosciences, Inc. (NERV) Prices IPO Below Range, Debuts At $6 Per Share 7/1/2014
San Diego's Ambrx, Inc. Withdraws Planned $86 Million IPO, Citing Market Conditions 7/1/2014
Former Genzyme Corporation (GENZ) Subsidiary rEVO Biologics Files For $75 Million IPO 7/1/2014
Immuno-Oncology Biotech Affimed Therapeutics AG Files For $75 Million IPO 6/30/2014
Seattle's Immune Design Corporation (IMDZ) Files For $60 Million IPO 6/27/2014
Luye Pharma Group Ltd. To Stage $764 Million IPO In Hong Kong 6/23/2014
Kite Pharma, Inc. Ups Proposed Deal Size To $120 Million, Raising Price Range To $17 Per Share 6/20/2014
Zafgen (ZFGN) Announces Pricing of Initial Public Offering 6/19/2014
GW Pharmaceuticals Eyes $148 Million In NASDAQ Offering 6/19/2014
Fremont Biotech Ardelyx Inc. (ARDX) Prices IPO At $14 Per Share 6/19/2014
Orthocell IPO Opens 6/5/2014
Biotech Aldeyra Therapeutics (ALDX) Prices Mini-IPO 5/2/2014
After Three Delays, SCYNEXIS, Inc. (SCYX) Finally Goes IPO At $10 A Share 5/2/2014
Organ Recovery Biotech Angion Biomedica Corp. Files For A $35 Million IPO 4/15/2014
Cerulean Pharma Inc. (CERU) Announces Pricing Of Initial Public Offering 4/10/2014
Emeryville's Adamas Pharmaceuticals (ADMS) IPO Prices At $16, Low End Of Range 4/10/2014
Bay Area's Corium International, Inc. Schedules In A $60 Million IPO 4/3/2014
Novo Nordisk A/S (NVO)'s IT Unit Appoints Advisers For Possible IPO 3/18/2014
Brushing Off Clinical Setback, Cerulean Pharma Inc. Tees Up $75 Million IPO 3/11/2014
Egalet IPO Underwriters Exercise Over-Allotment Option 3/10/2014
Vancouver's Aquinox Pharmaceuticals (AQXP) Prices Upsized IPO At $11, Raises $46 Million 3/7/2014
Week In Review: Jiangsu Aosaikang Pharma Delays China IPO 1/20/2014
San Diego's Auspex Pharmaceuticals Sets Terms For $61 Million IPO 1/17/2014
Cancer Diagnostic Developer Microlin Bio, Files For $25 Million IPO 1/13/2014
Innate Immunotherapeutics Completes $10 Million IPO 12/18/2013
Xencor Prices Initial Public Offering 12/3/2013
Kindred Bio Announces Launch Of Initial Public Offering 12/2/2013
uniQure Announces Confidential Submission of Draft Registration Statement for Initial Public Offering 11/11/2013
Fate Therapeutics (FATE) Bombs in IPO Debut, Prices at Low End of Revised Range 10/3/2013
Five Prime Therapeutics, Inc. (FPRX) Stock Soars After $62 Million IPO 9/18/2013
Beijing Genomics Institute (BGI) Shenzhen Plans IPO 9/3/2013
Cellular Dynamics International Sets Terms for $50 Million IPO 7/10/2013
Esperion Therapeutics, Inc. Prices Upsized $70 Million IPO for Statin Alternative Work 6/27/2013
bluebird bio Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option 6/25/2013
Belgian Heart Drug Firm Cardio3 BioSciences Launches IPO 6/21/2013
Belgian Heart Drug Firm Cardio3 BioSciences Plans to IPO in Paris, Brussels 6/5/2013
BioAmber Inc. Announces Closing of Initial Public Offering 5/15/2013
Epizyme Files Registration Statement for Proposed Initial Public Offering 4/26/2013